Anal cancer treatment regimen considerations for the COVID-19 era: In regard to Tchelebi et al

Radiother Oncol. 2020 Oct:151:56-57. doi: 10.1016/j.radonc.2020.07.028. Epub 2020 Jul 22.

¹ Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
² Department of Gastrointestinal Oncology, Vanderbilt-Ingram Cancer Center, Nashville, United States.
³ Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
⁴ Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States. Electronic address: prajdas@mdanderson.org.

No abstract available

Publication types